Antistaphylococcal activity of amoxicillin and ticarcillin when combined with clavulanic acid : evaluation of oxacillin-resistant and oxacillin-susceptible isolatesBARRY, A. L.Diagnostic microbiology and infectious disease. 1990, Vol 13, Num 5, pp 357-361, issn 0732-8893, 5 p.Article

Critical evaluation of amdinocillin disk susceptibility tests correlated with agar dilution testsBARRY, A. L.Journal of clinical microbiology (Print). 1986, Vol 23, Num 5, pp 983-985, issn 0095-1137Article

Nitrofurantoin susceptibility test criteriaBARRY, A. L.Journal of antimicrobial chemotherapy (Print). 1990, Vol 25, Num 4, pp 711-713, issn 0305-7453, 3 p.Article

Simple and rapid methods for bacterial identificationsBARRY, A. L.Clinics in laboratory medicine. 1985, Vol 5, Num 1, pp 3-17, issn 0272-2712Article

In vitro potency of nine orally administered antimicrobial agents against three respiratory tract pathogensBARRY, A. L.European journal of clinical microbiology & infectious diseases (Print). 1992, Vol 11, Num 9, pp 867-869, issn 0934-9723Article

Anaerobic susceptibility tests : differences between disc diffusion, agar dilution and broth microdilution test resultsBARRY, A. L.Journal of antimicrobial chemotherapy (Print). 1990, Vol 25, Num 5, pp 875-877, issn 0305-7453Article

In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution methodPFALLER, M. A; BARRY, A. L.Mycopathologia (1975). 1995, Vol 130, Num 1, pp 3-9, issn 0301-486XArticle

Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoixicillin, and amoxicillin-clavulanic acidFUCHS, P. C; BARRY, A. L.Journal of clinical microbiology (Print). 1994, Vol 32, Num 11, pp 2846-2850, issn 0095-1137Article

Performance of haemophilus test media prepared with 12 different lots of Mueller-Hinton Agar from four manufacturersBARRY, A. L; PACKER, R. R.Journal of clinical microbiology (Print). 1992, Vol 30, Num 5, pp 1145-1147, issn 0095-1137Article

Cross-resistance and cross-susceptibility between fluoroquinolone agentsBARRY, A. L; FUCHS, P. C.European journal of clinical microbiology & infectious diseases (Print). 1991, Vol 10, Num 12, pp 1013-1018, issn 0934-9723Article

Influence of the test medium on azithromycin and erythromycin regression statisticsBARRY, A. L; FUCHS, P. C.European journal of clinical microbiology & infectious diseases (Print). 1991, Vol 10, Num 10, pp 846-849, issn 0934-9723Article

In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinoloneJONES, R. N; BARRY, A. L.Antimicrobial agents and chemotherapy. 1990, Vol 34, Num 2, pp 306-313, issn 0066-4804Article

Interpretive criteria and quality control limits for ceftibuten disk susceptibility testsBARRY, A. L; JONES, R. N.Journal of clinical microbiology (Print). 1990, Vol 28, Num 3, pp 605-607, issn 0095-1137Article

Antibacterial activity of trospectomycin (U-63366F) and initial evaluations of disk diffusion susceptibility testsBARRY, A. L; JONES, R. N; THORNSBERRY, C et al.Antimicrobial agents and chemotherapy. 1989, Vol 33, Num 4, pp 569-572, issn 0066-4804Article

In-vitro studies of meropenemJONES, R. N; BARRY, A. L; THORNSBERRY, C et al.Journal of antimicrobial chemotherapy (Print). 1989, Vol 24, pp 9-29, issn 0305-7453, suppl. AConference Paper

In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycinBARRY, A. L; JONES, R. N; THORNSBERRY, C et al.Antimicrobial agents and chemotherapy. 1988, Vol 32, Num 5, pp 752-754, issn 0066-4804Article

Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporinJONES, R. N; BARRY, A. L.Antimicrobial agents and chemotherapy. 1988, Vol 32, Num 10, pp 1576-1582, issn 0066-4804Article

BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolatesJONES, R. N; BARRY, A. L.Diagnostic microbiology and infectious disease. 1988, Vol 9, Num 1, pp 11-26, issn 0732-8893Article

Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephemJONES, R. N; BARRY, A. L.Journal of clinical microbiology (Print). 1988, Vol 26, Num 4, pp 770-773, issn 0095-1137Article

Evaluation of in vitro methods for testing ceftriaxone against anaerobic bacteria, including quality control guidelinesBARRY, A. L; JONES, R. N.Journal of clinical microbiology (Print). 1988, Vol 26, Num 4, pp 776-777, issn 0095-1137Article

Activity of six contemporary antibacterial agents against 96 isolates from purulent meningitis: the contribution of desacetylcefotaxime to antimicrobial potencyJONES, R. N; BARRY, A. L.Journal of antimicrobial chemotherapy (Print). 1987, Vol 19, Num 6, pp 843-845, issn 0305-7453Article

The antimicrobial activity of A-56268 (TE-031) and roxithromycin (RU965) against Legionella using broth microdilution methodJONES, R. N; BARRY, A. L.Journal of antimicrobial chemotherapy (Print). 1987, Vol 19, Num 6, pp 841-842, issn 0305-7453Article

Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporinJONES, R. N; BARRY, A. L.Journal of clinical microbiology (Print). 1987, Vol 25, Num 11, pp 2211-2213, issn 0095-1137Article

In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl α-methoxyimino cephalosporinJONES, R. N; THORNBERRY, C; BARRY, A. L et al.Antimicrobial agents and chemotherapy. 1984, Vol 25, Num 6, pp 710-718, issn 0066-4804Article

Determination of susceptibility of anaerobic bacteria to cefotetan and cefoxitin by the thioglycolate disk elution methodBARRY, A. L; PACKER, R. R.Journal of clinical microbiology (Print). 1984, Vol 20, Num 5, pp 912-916, issn 0095-1137Article